MedTrace Logo

Exercise Capacity in COPD

NCT03889964 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-02-11

No results posted yet for this study

Summary

In this study, cardiopulmonary exercise will be assessed to characterize the relevance of severity of COPD and coexisting cardiovascular comorbidities for exercise capacity.

Conditions

Interventions

OTHER

Measurement of lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing

Measurement of lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing

Sponsors & Collaborators

  • Klinik für Kardiologie, Pneumologie und Angiologie

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03889964 on ClinicalTrials.gov